4.7 Article

Disease Modeling with Human Neurons Reveals LMNB1 Dysregulation Underlying DYT1 Dystonia

Journal

JOURNAL OF NEUROSCIENCE
Volume 41, Issue 9, Pages 2024-2038

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2507-20.2020

Keywords

cholinergic motor neurons; dystonia; human neurons; nuclear LMNB1; nucleocytoplasmic transport; TOR1A

Categories

Funding

  1. Welch Foundation [I-1724]
  2. Texas Alzheimer's Research Consortium (TARCC)
  3. Decherd Foundation
  4. Pape Adams Foundation
  5. Kent Waldrep Foundation Center for Basic Research on Nerve Growth and Regeneration, National Institutes of Health (NIH) [NS092616, NS099073, NS111776, NS117065, NS112910]
  6. Friends of the Alzheimer's Disease Center (ADC)
  7. NIH ADC Grant [NIH/NIA P30-12300-21]
  8. Department of Defense Peer Reviewed Medical Research Program (PRMRP) [W81XWH2010186]
  9. National Natural Sciences Foundation of China [81801200]
  10. Hunan Provincial Natural Science Foundation of China [2019JJ40476]
  11. University of Texas Southwestern Electron Microscopy Core
  12. Microscopy Center at the University of Louisiana at Lafayette
  13. U.S. Department of Defense (DOD) [W81XWH2010186] Funding Source: U.S. Department of Defense (DOD)

Ask authors/readers for more resources

DYT1 dystonia is a hereditary neurologic movement disorder caused by a mutation in the TOR1A gene encoding an ATPase. Modeling the disease using patient-specific neurons revealed that dysregulation of the nuclear lamina protein LMNB1 could be a major molecular mechanism underlying DYT1 pathology.
DYT1 dystonia is a hereditary neurologic movement disorder characterized by uncontrollable muscle contractions. It is caused by a heterozygous mutation in Torsin A (TOR1A), a gene encoding a membrane-embedded ATPase. While animal models provide insights into disease mechanisms, significant species-dependent differences exist since animals with the identical heterozygous mutation fail to show pathology. Here, we model DYT1 by using human patient-specific cholinergic motor neurons (MNs) that are generated through either direct conversion of patients' skin fibroblasts or differentiation of induced pluripotent stem cells (iPSCs). These human MNs with the heterozygous TOR1A mutation show reduced neurite length and branches, markedly thickened nuclear lamina, disrupted nuclear morphology, and impaired nucleocytoplasmic transport (NCT) of mRNAs and proteins, whereas they lack the perinuclear blebs that are often observed in animal models. Furthermore, we uncover that the nuclear lamina protein LMNB1 is upregulated in DYT1 cells and exhibits abnormal subcellular distribution in a cholinergic MNs-specific manner. Such dysregulation of LMNB1 can be recapitulated by either ectopic expression of the mutant TOR1A gene or shRNA-mediated downregulation of endogenous TOR1A in healthy control MNs. Interestingly, downregulation of LMNB1 can largely ameliorate all the cellular defects in DYT1 MNs. These results reveal the value of disease modeling with human patient-specific neurons and indicate that dysregulation of LMNB1, a crucial component of the nuclear lamina, may constitute a major molecular mechanism underlying DYT1 pathology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available